Sonnet BioTherapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Derivative Liability - Schedule of Assumptions Used in Fair Value of the Derivative Liability (Details)		3 Months Ended
	Feb. 07, 2020	Mar. 31, 2020 Integer
Derivative liability measurement input		19
Parent Company [Member] \| Expected Volatility [Member]
Derivative liability measurement input	0	0.00
Parent Company [Member] \| Dividend Yield [Member]
Derivative liability measurement input	83	110
Parent Company [Member] \| Risk Free Interest Rate [Member]
Derivative liability measurement input	0.13	0
Parent Company [Member] \| Expected Term [Member]
Derivative liability measurement input, Expected remaining term (in years)	6 months	42 months 21 days
Amergent Hospitality Group, Inc. [Member] \| Expected Volatility [Member]
Derivative liability measurement input		0.00
Amergent Hospitality Group, Inc. [Member] \| Dividend Yield [Member]
Derivative liability measurement input		134
Amergent Hospitality Group, Inc. [Member] \| Risk Free Interest Rate [Member]
Derivative liability measurement input		0.13
Amergent Hospitality Group, Inc. [Member] \| Expected Term [Member]
Derivative liability measurement input, Expected remaining term (in years)		42 months 21 days